MoneyWorks4Me

The company witnessed a 19.30% growth in the revenue at Rs. 15094.20 millions for the quarter ended December 2025 as compared to Rs. 12651.90 millions during the year-ago period.The Net Profit of the company vaulted to 205.71% to Rs. 1750.80  millions from Rs. 572.70 millions in the previous quarter.The company reported a good operating profit of 3602.30 millions compared to 2134.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 15094.20 12651.90 19.30 45087.70 35669.70 26.40 52169.80 48123.90 8.41
Other Income 143.70 71.20 101.83 643.40 283.10 127.27 1004.70 474.20 111.87
PBIDT 3602.30 2134.00 68.81 11272.40 5778.10 95.09 10448.00 7973.00 31.04
Interest 314.80 480.20 -34.44 1090.50 1336.00 -18.38 1822.00 1508.20 20.81
PBDT 3287.50 1653.80 98.78 10181.90 4442.10 129.21 8626.00 6464.80 33.43
Depreciation 943.10 886.60 6.37 2834.70 2706.00 4.76 3587.90 3450.10 3.99
PBT 2344.40 767.20 205.58 7347.20 1736.10 323.20 5038.10 3014.70 67.12
TAX 593.60 194.50 205.19 1860.30 451.20 312.30 1234.20 777.70 58.70
Deferred Tax -96.70 -130.90 -26.13 -305.90 -266.50 14.78 -304.20 -101.70 199.12
PAT 1750.80 572.70 205.71 5486.90 1284.90 327.03 3803.90 2237.00 70.04
Equity 1079.70 1078.50 0.11 1079.70 1078.50 0.11 1078.50 1077.90 0.06
PBIDTM(%) 23.87 16.87 41.49 25.00 16.20 54.34 20.03 16.57 20.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..